Pulse Oximeter Market (2025-2032)
The Pulse Oximeter Market was valued at $2.23 billion in 2024. This market is expected to reach $3.4 billion by 2032, from an estimated $2.36 billion in 2025, at a CAGR of 5.4% during the forecast period 2025-2032. Pulse Oximeter Market Size & Forecast The growth of this market is primarily driven
- Published
- May 2024
- Pages
- 250
- Format
- PDF + Excel
- Report ID
- MRHC - 1041184
- Base year
- 2024
- 2024 · BASELINE
- $2.23B
- 2032
- $3.40B
- CAGR 2025–2032
- 5.4%
2024 baseline · 2025–2032 forecast at 5.4% CAGR · hover a bar for the value
Key highlights
By Component: The Devices Segment to Dominate the Pulse Oximeter Market in 2025
By Portability: The Handheld Pulse Oximeters Segment to Dominate the Pulse Oximeter Market in 2025
By Technology: The Conventional Pulse Oximeters Segment to Dominate the Pulse Oximeter Market in 2025
By Age Group: The Adults Segment to Dominate the Pulse Oximeter Market in 2025
By End User: The Hospitals & Clinics Segment to Dominate the Pulse Oximeter Market in 2025
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | 250 |
| Format | |
| Forecast Period | 2025–2032 |
| Base Year | 2024 |
| CAGR (Value) | 5.4% |
| CAGR (Volume) | NA |
| Market Size (Value) | $3.40 Billion by 2032 |
| Market Size (Volume) | NA |
| Segments Covered | By Component · Devices · Prescription Pulse Oximeters · Over-the-counter (OTC) Pulse Oximeters · Sensors · Disposable SpO2 Sensors · Reusable SpO2 Sensors · By Portability · Handheld Pulse Oximeters · Fingertip Pulse Oximeters · Wearable Pulse Oximeters · Bench-top Pulse Oximeters · By Technology · Conventional Pulse Oximeters · Connected Pulse Oximeters · By Age Group · Adults · Pediatrics · Fetal Monitoring · Neonatal Monitoring · Infant Monitoring · By End User · Hospitals & Clinics · Home Care Settings · Ambulatory Care Centers · Other End Users · (Note: Other end users include long-term care facilities, fitness & wellness centers, and public facilities.) |
| Countries Covered | North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Ireland, Denmark, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa |
| Key Companies Profiled | Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies, Inc. (U.S.), Masimo Corporation (U.S.), Beurer GmbH (Germany), Nonin Medical, Inc. (U.S.), Nihon Kohden Corporation (Japan), Drägerwerk AG & Co. KGaA (Germany), ICU Medical, Inc. (U.S.), and Spacelabs Healthcare (a subsidiary of OSI Systems, Inc.) (U.S.) |
Report overview
Segments covered: component, device, prescription pulse oximeter, sensor, disposable spo2 sensor, reusable spo2 sensor, portability, handheld pulse oximeter, fingertip pulse oximeter, wearable pulse oximeter, bench-top pulse oximeter, technology, conventional pulse oximeter, connected pulse oximeter, age group, adult, pediatric, fetal monitoring, neonatal monitoring, infant monitoring, end user, hospitals & clinic, home care setting, ambulatory care center, other end user. Regions: North America, Europe, Asia-Pacific, Latin America.
The growth of this market is primarily driven by the rising number of hospitalizations, the use of pulse oximeters in newborn screening, the growing incidence of Chronic Obstructive Pulmonary Disorder (COPD) and asthma, and the increasing penetration of OTC pulse oximeters. Moreover, technological advancements in pulse oximeters, the increasing adoption of wearable devices, and advancements in sensor technologies are expected to create growth opportunities for the players operating in this market.
Report infographic
Market dynamics
4 factors across 3 forcesUse of Pulse Oximeters in Newborn Screening
Pulse oximetry is a painless and non-invasive technique employed to measure oxygen levels in a newborn’s blood. The primary purpose of this test is to identify heart-related issues, particularly Critical Congenital Heart Disease (CCHD), in newborns who exhibit low levels of blood oxygen. Congenital heart disease requires early detection following the birth of a child. If left undetected shortly after birth, children are susceptible to the potential risks of mortality or disability. According to the CDC, Congenital Heart Defects (CHD) occur in about 1 in 110 births in the U.S. Approximately 25% of these cases are Critical Congenital Heart Defects (CCHD). Children born with CCHD need surgery or other procedures within the first year of their life.
The protocol for screening a newborn for CCHD is standard across most countries. Initial screening is recommended when the newborn is 24-36 hours old. Newborns with a failed pulse oximetry test may undergo an electrocardiogram (ECG) or a chest x-ray as per assessment by their healthcare providers, such as doctors, nurses, and midwives.
Table of contents
13 chapters · 109 sections · 250 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Component | Devices | — |
| By Portability | Handheld Pulse Oximeters | — |
| By Technology | Conventional Pulse Oximeters | — |
| By Age Group | Adults | — |
| By End User | Hospitals & Clinics | Home care settings |
By Component
- The Devices Segment to Dominate the Pulse Oximeter Market in 2025
- The devices segment is expected to account for the larger share of 57% of the pulse oximeter market.
- The large share of this segment is attributed to factors such as the increasing penetration of OTC devices, the rising demand for home care, and the high prevalence of chronic lung disorders such as COPD.
- The emergence of remote patient monitoring and telemedicine has boosted the demand for home healthcare.
- The use of pulse oximeters allows patients to track their oxygen saturation levels at home without needing to visit a healthcare facility.
- The devices segment is further subsegmented into prescription pulse oximeters and over-the-counter pulse oximeters.
- The over-the-counter (OTC) pulse oximeters segment is expected to record the higher CAGR of 8.5% during the forecast period 2025–2032.
- OTC pulse oximeters are gaining popularity due to non-medical applications, such as general wellness, fitness tracking, and sports activities.
- Certain companies have received regulatory approvals for OTC devices to be sold individually without prescriptions.
- For instance, in February 2025, Masimo Corporation (U.S.) received FDA clearance for its MightySat Medical OTC fingertip pulse oximeter, which offers hospital-grade pulse oximetry technology and can be sold at drug stores.
- Thus, the increasing penetration of OTC devices for both medical and non-medical applications is driving the growth of the devices segment.
By Portability
- The handheld pulse oximeters segment is expected to account for the largest share of 42% of the pulse oximeter market.
- Handheld pulse oximeters are generally used in professional healthcare settings and are easier to use in cases of emergency.
- The large market share of the segment is attributed to the increasing incidence of respiratory disorders coupled with the rising number of hospitalizations.
- The growing demand for handheld devices has encouraged key market players to launch advanced handheld pulse oximetry devices.
- For instance, in September 2020, Masimo Corporation (U.S.) received the U.S. Food and Drug Administration (U.S. FDA) approval for its Rad-G Pulse Oximeter, a handheld device that provides SET pulse oximetry, respiration rate from the pleth (RRp), and other vital parameters for spot-checking as well as continuous monitoring.
By Technology
- The conventional pulse oximeters segment is expected to account for the larger share of 55% of the pulse oximeter market.
- The large share of the segment is attributed to the widespread use and availability of conventional pulse oximeters.
- The increasing burden of respiratory disorders is driving hospital admissions globally.
- Conventional pulse oximeters are widely used across healthcare settings due to their accuracy and ease of handling for medical professionals.
- Thus, the usage of conventional pulse oximeters is higher across both developed as well as developing countries.
- However, the connected pulse oximeters segment is expected to record the higher CAGR over the forecast period, primarily due to the gradual increase in the adoption of connected devices for remote patient monitoring, patients’ growing interest in health monitoring, and the ability of connected devices to integrate with broader health ecosystems such as Electronic Health Records (EHRs) and other health monitoring devices.
- Connected pulse oximeters are being introduced with companion apps or platforms to provide features such as trend analysis, data storage, and personalized insights.
- Patients can thus track changes in their oxygen levels over time, identify patterns, and receive recommendations for improving their health.
- Thus, the adoption of connected devices is expected to rise over the forecast period.
By Age Group
- The Adults Segment to Dominate the Pulse Oximeter Market in 2025
- The adults segment is expected to account for the larger share of 62% of the pulse oximeter market.
- The large share of the segment is attributed to the growing incidence of disorders such as Chronic Obstructive Pulmonary Disease (COPD) and asthma, the increasing adoption of wearable devices for remote monitoring, and the growing interest in continuous health monitoring.
- The prevalence of COPD and other lung disorders is higher in adults compared to children.
- Further, occupational risks are propelling the incidence of respiratory disorders among adults, contributing to the segment’s large share.
By End User
- The hospitals & clinics segment is expected to account for the largest share of 45% of the pulse oximeter market.
- Hospitals & clinics are the primary and most accessible healthcare settings for patients to receive disease diagnosis, monitoring, and treatment.
- The rising disease burden has increased the number of hospital admissions.
- Pulse oximeters are widely used across hospitals & clinics to monitor patient vitals.
- Thus, the high demand for pulse oximeters for vital sign monitoring and continuous monitoring of critical care patients drives the adoption of pulse oximeters among hospitals & clinics, supporting the segment’s large share.
- However, the home care settings segment is expected to record the highest CAGR of 6.90% during the forecast period 2025–2032.
- The high growth of this segment is attributed to the growing shift toward home care settings, the rise in chronic diseases among the elderly population necessitating home-based care and increasing consumer awareness regarding the monitoring of chronic conditions.
- Owing to the growing popularity of pulse oximeters in home care settings, key market players are launching pulse oximeters suited to home care.
- For instance, in January 2021, TytoCare Ltd. (Israel) launched a pulse oximeter that enables people to check their oxygen levels and heart rate at home.
- This device can be connected to the Tyto Care platform, where all the readings from the device are recorded and can be analyzed by healthcare professionals.
Geographic analysis
North America
Largest shareIn 2025, North America is expected to account for the largest share of 42% of the pulse oximeter market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America’s large share is primarily attributed to the high prevalence of chronic diseases, the presence of advanced healthcare facilities, increasing digitalization in healthcare, and the presence of key market players. In recent years, the prevalence of chronic diseases in the U.S. has increased, especially among older adults, necessitating hospital admissions and long-term home care. The number of people aged 65 or above in the U.S. is expected to increase from 53 million in 2019 to 70 million by 2032 (Source: United Nations). Moreover, the emergence of remote monitoring devices has allowed healthcare payers to cover remote monitoring services and products in health insurance claims. The use of devices such as pulse oximeters at home (or remotely) is likely to minimize hospital visits, especially for older adults, and promote chronic disease care at home, ultimately reducing healthcare costs.
Asia-Pacific
Fastest growthHowever, Asia-Pacific is slated to register the highest CAGR of 7.50% during the forecast period, mainly due to the increasing prevalence of chronic diseases coupled with growth in the aging population, the shortage of healthcare professionals, the uneven regional distribution of healthcare services, rising digitalization and internet penetration, and improving government rules and regulations. Growing spending on healthcare and the trend of self-monitoring as a preventive health measure further support the growth of this segment.
Competitive landscape
- November 2024
GE Healthcare Technologies, Inc. (U.S.) and Masimo Corporation (U.S.) collaborated to integrate Masimo’s Signal Extraction Technology (SET) pulse oximetry into GE’s Portrait Mobile, which is a wireless and wearable patient monitoring solution.
- March 2024
BioIntelliSense, Inc. (U.S.) launched its patented U.S. FDA-approved pulse oximetry (SpO2) sensor chipset and integrated processing technology that can accurately measure blood oxygen levels across light to very dark skin pigmentations and during movement and activity.
- February 2024
Heal Force Bio-Meditech Holdings Limited (China) launched the Heal Force FS Series Pulse Oximeter, which monitors the blood oxygen saturation and pulse rate indicators of elderly patients in real time.
- March 2021
Nonin Medical, Inc. (U.S.) launched two disposable products: a single-use wristband and a sensor to be used with Nonin’s Wrist Ox2 3150 wrist-worn pulse oximeter (SpO2). This cost-effective solution reduces patients’ as well as healthcare providers’ exposure to infectious agents.
- Medtronic plc · Ireland
- Koninklijke Philips N.V. · Netherlands
- GE HealthCare Technologies, Inc. (U.S.)
- Masimo Corporation (U.S.)
- Beurer GmbH · Germany
- Nonin Medical, Inc. (U.S.)
- Nihon Kohden Corporation · Japan
- Drägerwerk AG & Co. KGaA · Germany
- ICU Medical, Inc. (U.S.)
Frequently asked questions
The Pulse Oximeter Market refers to the sector that deals with the production, distribution, and sales of pulse oximeters, which are medical devices used to measure the oxygen saturation levels in a person’s blood. These devices are essential in various healthcare settings, including hospitals, clinics, and home care environments, for monitoring respiratory conditions and other health issues.
Cite this report
Meticulous Research. (2024). Pulse Oximeter Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 1041184). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/pulse-oximeter-market-5867